AstraZeneca to set up division for vaccines and antibody therapies
AstraZeneca is creating a separate division for vaccines and antibody therapies, the drugmaker said on Tuesday, to focus on its COVID-19 shot and coronavirus treatments after a series of setbacks during the pandemic